138 results on '"Krishnamurthi, Smitha S."'
Search Results
2. Plasma metabolomic differences in early-onset compared to average-onset colorectal cancer
3. Preoperative Strategies for Locally Advanced Colon Cancer
4. Prognostic and predictive role of circulating tumor DNA (ctDNA) in stage III colon cancer treated with celecoxib: Findings from CALGB (Alliance)/SWOG 80702.
5. Preliminary results from a randomized, open-label, phase 2 study of botensilimab (BOT) with or without balstilimab (BAL) in refractory microsatellite stable metastatic colorectal cancer with no liver metastases (MSS mCRC NLM).
6. Is Early, Postinduction Restaging of Rectal Cancer Undergoing Total Neoadjuvant Therapy Associated With Ultimate Treatment Response?
7. What Predicts Complete Response to Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer?
8. Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors
9. Data from A Blueprint to Advance Colorectal Cancer Immunotherapies
10. Supplemental Table 2 from A Blueprint to Advance Colorectal Cancer Immunotherapies
11. Supplemental Table 1 from A Blueprint to Advance Colorectal Cancer Immunotherapies
12. Supplemental Table Legends from A Blueprint to Advance Colorectal Cancer Immunotherapies
13. Supplementary Materials and Methods from Phase I Study of Bosutinib, a Src/Abl Tyrosine Kinase Inhibitor, Administered to Patients with Advanced Solid Tumors
14. Supplementary Figure 1 from Phase I Study of Bosutinib, a Src/Abl Tyrosine Kinase Inhibitor, Administered to Patients with Advanced Solid Tumors
15. Supplementary Data from 5-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against PIK3CA-Mutant Colorectal Cancers
16. HCRN GI16-288: A phase II trial of perioperative CV301 vaccination in combination with nivolumab and systemic chemotherapy for resectable hepatic-limited metastatic colorectal cancer—Preliminary efficacy and correlative results.
17. Overall survival (OS) in gastrointestinal (GI) neuroendocrine tumors (NETs) based on primary site, stage, and surgery.
18. Metabolomic differences in young-onset versus average-onset colorectal adenocarcinoma.
19. Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer
20. Comparison of characteristics and outcomes of young‐onset versus average onset pancreatico‐biliary adenocarcinoma
21. A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors
22. Phase II Study of Irinotecan and Cetuximab Given Every 2 Weeks as Second-Line Therapy for Advanced Colorectal Cancer
23. Comparison of characteristics and outcomes of young onset versus average onset pancreatobiliary adenocarcinoma.
24. Computerized features of tumor diversity on pre-chemoradiation MRI are associated with pathologic complete response in rectal cancers: A multi-institutional study.
25. Expert Commentary on ctDNA Testing for Minimal Residual Disease Assessment and Surveillance.
26. Updates in the Treatment of Patients With Colorectal Cancer
27. Deep hybrid convolutional wavelet networks: application to predicting response to chemoradiation in rectal cancers via MRI
28. Comparison of comprehensive genomic profiles between young-onset and average-onset colorectal cancer.
29. The effects of liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular endothelial growth factor receptor tyrosine kinases
30. Racial disparities negatively impact outcomes in early‐onset colorectal cancer independent of socioeconomic status
31. Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors
32. A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma
33. Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine
34. A pilot study of a low glycemic load diet in patients with stage I-III colorectal cancer
35. Evaluation and management of incidental thyroid nodules in patients with another primary malignancy
36. A phase II study of atezolizumab (ATEZO) and bevacizumab (Bev) in combination with Y90 TARE in patients (Pts) with hepatocellular carcinoma (HCC).
37. Racial disparities negatively impact outcomes for patients with early-onset colorectal cancer independent of income or education status.
38. 5-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against PIK3CA-Mutant Colorectal Cancers
39. Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors
40. A pilot study to determine the feasibility of a customized low glycemic load diet in patients with stage I-III colorectal cancer.
41. Video conference intervention for distance caregivers (DCGs) of patients with cancer: Improving psychological outcomes.
42. Video conferencing long distance caregivers during oncology appointments: Implications for clinical practice.
43. Adjuvant Therapy for Rectal Cancer
44. A pilot clinical trial of p53/p16-independent epigenetic therapy for pancreatic ductal adenocarcinoma (PDA).
45. Deep hybrid convolutional wavelet networks: application to predicting response to chemoradiation in rectal cancers via MRI
46. Correlation of overall survival (OS) in patients (pts) with inoperable hepatocellular carcinoma (iHCC) receiving tivozanib (TIVO) with baseline performance status.
47. Phase I clinical trial of the glutaminase inhibitor CB-839 plus capecitabine in patients with advanced solid tumors.
48. Phase 1b/2 study of tivozanib in patients with advanced inoperable hepatocellular carcinoma.
49. A Blueprint to Advance Colorectal Cancer Immunotherapies
50. Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.